Efficacy and compliance of specific immunotherapy in allergic rhinitis.
- Author:
Li KUANG
1
;
Huiling FENG
;
Bingbin XIE
Author Information
1. Department of Otorhinolaryngology, Foshan Traditional Chinese Medical Hospital, Foshan, 528000, China. YE95226@126.com
- Publication Type:Journal Article
- MeSH:
Adolescent;
Adult;
Child;
Child, Preschool;
Desensitization, Immunologic;
Female;
Humans;
Male;
Middle Aged;
Patient Compliance;
Rhinitis, Allergic, Perennial;
therapy;
Rhinitis, Allergic, Seasonal;
therapy;
Treatment Outcome;
Young Adult
- From:
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
2012;26(2):56-58
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To evaluate the efficacy, safety and compliance of specific immunotherapy in allergic rhinitis.
METHOD:Two hundred and eighty cases with allergic rhinitis were undertaken immunotherapy, and then were observed its symptoms, signs and treatment by graded score.
RESULT:Total effective rate was 86.8%, 70.4%, 62.5% at 16 week, 6 months and 1 year after treatment. Of 280 patients treated, 74 patients stopped treatment after one year, compliance rate was 73.6%.
CONCLUSION:Specific immunotherapy is a safe and effective treatment methods for allergic rhinitis and worthy of attention and promotion, while strengthening the health education is needed to improve treatment compliance of patients.
